The Biosimilars Implementation Roadmap is an innovative learning tool that can help multidisciplinary cancer care teams obtain the knowledge they need to implement, expand, and sustain biosimilars as a treatment option for patients with cancer. The Roadmap will give users information about how to lay the groundwork for biosimilars, train and prepare their care team to offer biosimilars, implement biosimilars, and evaluate ongoing progress. “Expert Insights” from the Advisory Committee that informed the Roadmap give teams a deeper understanding of how biosimilars fit into their cancer program. Accompanying resources provide more information and are available in the Resource Library.
Funding & support provided by Pfizer, Amgen, and Coherus.